𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Cornell Medical Index as a prognostic aid for complete denture patients

✍ Scribed by Charles L. Bolender; Charles C. Swoope; Dale E. Smith

Book ID
118920384
Publisher
Elsevier Science
Year
1969
Tongue
English
Weight
660 KB
Volume
22
Category
Article
ISSN
1097-6841

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The fucosylation index of Ξ±-fetoprotein
The fucosylation index of Ξ±-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma
✍ Yutaka Aoyagi; Osamu Isokawa; Takeshi Suda; Masashi Watanabe; Yasufumi Suzuki; H πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

The aim of this study was to elucidate the usefulness of measuring the fucosylation index (FI) of ␣-fetoprotein (AFP) before the initiation of therapy as a new prognostic indicator for patients with hepatocellular carcinoma (HCC). ## METHODS. One hundred twelve patients with HCC who underwent tran

The proliferation index of MIB-1 as a pr
The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract
✍ Golam M. Chowdhury; Keiji Kojima; Hiro-omi Kanayama; Masahito Tsuji; Yasushi Kur πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

## BACKGROUND. Recently, several reports have shown that immunohistochemical analysis using MIB-1 antibody, which recognizes Ki-67 (a human nuclear antigen expressed of proliferating cells), is a useful method for determining the proliferative activity of various cancers. In this study, the author

Final report on the University of Califo
Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients
✍ Kathleen R. Lamborn; Michael D. Prados; Sarah B. Kaplan; Richard L. Davis πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Background: At the university of california-san francisco (ucsf), a labeling index (li) based on in vivo administration of bromodeoxyuridine (budr) was routinely determined in tumors from patients with infiltrating gliomas for the 10-year period, 1984-1994. considered an indicator of tumor proli